Spruce Biosciences, Inc.

SPRBNASDAQHealthcare● Active

$49.32

$-1.11(-2.20%)

Market Cap$67668470

P/E Ratio—

52W High$838.125

52W Low$7

Avg Volume62K

Open$50.40

Beta3.16

Insider Trades Ownership Employees

Spruce Biosciences, Inc.（SPRB）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · SPRB · 截至 2026年6月9日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

0.50

Buy/Sell (by trades)

整体情绪

偏空

↑ Buy 33%仅显示有效交易 · 排除RSU归属67% Sell ↓

Spruce Biosciences, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月9日

SPRB 季度内部人买卖趋势

SPRB 内幕交易卖出 · SPRB 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

4.2M2.1M0

2023 Q2

2023 Q4

2024 Q1

2024 Q2

2024 Q4

2025 Q3

2025 Q4

2026 Q1

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 9, 2026

活跃内部人

近12个月交易最活跃 · SPRB CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

SPRB 高管卖出股份 · SPRB 董事内幕交易 · SEC Form 4申报

显示最近 22 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Dec 11, 2025	Ways Douglas Kirk Interim Chief Medical Officer · Director	Option	1,250	—	—	1,250	Form 4
Dec 31, 2025	Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER · Director	Award	4,690	$4.53	$21K	19,004	Form 4
Dec 15, 2025	Gharib Samir M. PRESIDENT AND CFO	Option	513	—	—	8,447	Form 4
Dec 15, 2025	Gharib Samir M. PRESIDENT AND CFO	Other	184	$80.67	$15K	8,263	Form 4
Dec 15, 2025	Gharib Samir M. PRESIDENT AND CFO	Option	496	—	—	8,112	Form 4
Dec 15, 2025	Gharib Samir M. PRESIDENT AND CFO	Other	178	$80.67	$14K	7,934	Form 4
Dec 15, 2025	Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER · Director	Option	1,196	—	—	14,922	Form 4
Dec 15, 2025	Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER · Director	Option	1,480	—	—	14,478	Form 4
Dec 15, 2025	Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER · Director	Other	608	$80.67	$49K	14,314	Form 4
Dec 15, 2025	Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER · Director	Other	752	$80.67	$61K	13,726	Form 4
Dec 11, 2025	Gharib Samir M. PRESIDENT AND CFO	Option	1,900	—	—	8,296	Form 4
Dec 11, 2025	Gharib Samir M. PRESIDENT AND CFO	Other	680	$88.41	$60K	7,616	Form 4
Dec 10, 2025	Gharib Samir M. PRESIDENT AND CFO	Option	514	—	—	6,580	Form 4
Dec 10, 2025	Gharib Samir M. PRESIDENT AND CFO	Other	184	$85.67	$16K	6,396	Form 4
Dec 11, 2025	Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER · Director	Option	4,950	—	—	15,192	Form 4
Dec 11, 2025	Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER · Director	Other	2,194	$88.41	$194K	12,998	Form 4
Dec 10, 2025	Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER · Director	Option	1,196	—	—	10,670	Form 4
Dec 10, 2025	Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER · Director	Other	428	$85.67	$37K	10,242	Form 4
Oct 20, 2025	Gharib Samir M. PRESIDENT AND CFO	Option	2,053	—	—	6,727	Form 4
Oct 20, 2025	Gharib Samir M. PRESIDENT AND CFO	Other	661	$148.16	$98K	6,066	Form 4
Oct 20, 2025	Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER · Director	Option	4,784	—	—	11,013	Form 4
Oct 20, 2025	Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER · Director	Other	1,539	$148.16	$228K	9,474	Form 4

Ways Douglas Kirk

Interim Chief Medical Officer · Director

Option

日期

Dec 11

股数

1,250

均价

—

总金额

—

View Form 4 on SEC.gov

Szwarcberg Javier B.

CHIEF EXECUTIVE OFFICER · Director

Award

日期

Dec 31

股数

4,690

均价

$4.53

总金额

$21K

View Form 4 on SEC.gov

Gharib Samir M.

PRESIDENT AND CFO

Option

日期

Dec 15

股数

513

均价

—

总金额

—

View Form 4 on SEC.gov

Gharib Samir M.

PRESIDENT AND CFO

Other

日期

Dec 15

股数

184

均价

$80.67

总金额

$15K

View Form 4 on SEC.gov

Gharib Samir M.

PRESIDENT AND CFO

Option

日期

Dec 15

股数

496

均价

—

总金额

—

View Form 4 on SEC.gov

Gharib Samir M.

PRESIDENT AND CFO

Other

日期

Dec 15

股数

178

均价

$80.67

总金额

$14K

View Form 4 on SEC.gov

Szwarcberg Javier B.

CHIEF EXECUTIVE OFFICER · Director

Option

日期

Dec 15

股数

1,196

均价

—

总金额

—

View Form 4 on SEC.gov

Szwarcberg Javier B.

CHIEF EXECUTIVE OFFICER · Director

Option

日期

Dec 15

股数

1,480

均价

—

总金额

—

View Form 4 on SEC.gov

Szwarcberg Javier B.

CHIEF EXECUTIVE OFFICER · Director

Other

日期

Dec 15

股数

608

均价

$80.67

总金额

$49K

View Form 4 on SEC.gov

Szwarcberg Javier B.

CHIEF EXECUTIVE OFFICER · Director

Other

日期

Dec 15

股数

752

均价

$80.67

总金额

$61K

View Form 4 on SEC.gov

Gharib Samir M.

PRESIDENT AND CFO

Option

日期

Dec 11

股数

1,900

均价

—

总金额

—

View Form 4 on SEC.gov

Gharib Samir M.

PRESIDENT AND CFO

Other

日期

Dec 11

股数

680

均价

$88.41

总金额

$60K

View Form 4 on SEC.gov

Gharib Samir M.

PRESIDENT AND CFO

Option

日期

Dec 10

股数

514

均价

—

总金额

—

View Form 4 on SEC.gov

Gharib Samir M.

PRESIDENT AND CFO

Other

日期

Dec 10

股数

184

均价

$85.67

总金额

$16K

View Form 4 on SEC.gov

Szwarcberg Javier B.

CHIEF EXECUTIVE OFFICER · Director

Option

日期

Dec 11

股数

4,950

均价

—

总金额

—

View Form 4 on SEC.gov

Szwarcberg Javier B.

CHIEF EXECUTIVE OFFICER · Director

Other

日期

Dec 11

股数

2,194

均价

$88.41

总金额

$194K

View Form 4 on SEC.gov

Szwarcberg Javier B.

CHIEF EXECUTIVE OFFICER · Director

Option

日期

Dec 10

股数

1,196

均价

—

总金额

—

View Form 4 on SEC.gov

Szwarcberg Javier B.

CHIEF EXECUTIVE OFFICER · Director

Other

日期

Dec 10

股数

428

均价

$85.67

总金额

$37K

View Form 4 on SEC.gov

Gharib Samir M.

PRESIDENT AND CFO

Option

日期

Oct 20

股数

2,053

均价

—

总金额

—

View Form 4 on SEC.gov

Gharib Samir M.

PRESIDENT AND CFO

Other

日期

Oct 20

股数

661

均价

$148.16

总金额

$98K

View Form 4 on SEC.gov

Szwarcberg Javier B.

CHIEF EXECUTIVE OFFICER · Director

Option

日期

Oct 20

股数

4,784

均价

—

总金额

—

View Form 4 on SEC.gov

Szwarcberg Javier B.

CHIEF EXECUTIVE OFFICER · Director

Other

日期

Oct 20

股数

1,539

均价

$148.16

总金额

$228K

View Form 4 on SEC.gov

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 SPRB 内幕交易

SPRB 内幕交易

Spruce Biosciences, Inc.（SPRB）内幕交易数据来源于公司内部人（包括Szwarcberg Javier B. (CHIEF EXECUTIVE OFFICER · Director), Gharib Samir M. (PRESIDENT AND CFO), Ways Douglas Kirk (Interim Chief Medical Officer · Director)）提交的SEC Form 4申报文件。过去12个月内，3位内部人向SEC提交了交易申报。SPRB内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Spruce Biosciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

SPRB 内幕交易 · 5个问题

Spruce Biosciences, Inc.（SPRB）的内部人包括高管和董事，如Szwarcberg Javier B. (CHIEF EXECUTIVE OFFICER · Director), Gharib Samir M. (PRESIDENT AND CFO), Ways Douglas Kirk (Interim Chief Medical Officer · Director)等。过去12个月内，3位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

SPRB 董事内幕交易SPRB 内部人名单Spruce Biosciences, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026